Table 2.
Reports of AIH triggered by HAV infection.
| Age | Sex | Interval (wk) | IgG (mg/dL) | Therapy | |
| Vent S, et al (1991) | 13 | F | 17 | N.D. | Steroid |
| Vent S, et al (1991) | 18 | M | 19 | N.D. | Steroid |
| Rahaman SM, et al (1992) | 55 | F | 10 | 2070 | Steroid |
| Huppertz HI, et al (1993) | 7 | M | 10 | 3700 | Steroid |
| Oshikata S, et al (1996) | 70 | M | 28 | 2313 | Steroid |
| Hilzenrat N, et al (1999) | 55 | F | N.D. | N.D. | Steroid |
| Tamura T, et al (2000) | 39 | F | 8 | 2219 | Steroid |
| Present case | 48 | F | 16 | 2040 | UDCA |
N.D.: not described. Interval: from hepatitis A infection to onset of AIH (wk).